https://www.selleckchem.com/pr....oducts/XL880(GSK1363
81 ± 5.46μg/ml) compared to those who relapsed to active disease (5.68 ± 3.70, p 0.001). Overall, participants with a mean infliximab trough concentration greater than 8ug/ml were more likely to have histologic remission (area under the receiver operating characteristic curve, AUROC = 0.72, 95%CI = 0.65-0.84, p 0.0001) and sustained histologic remission (AUC = 0.77, 95%CI = 0.63-0.91, p = 0.002). Maintenance-phase infliximab trough concentrations greater than 8μg/ml, which is higher than the currently recom
Like
Comment
Share
